AB Science Statistics
Total Valuation
AB Science has a market cap or net worth of 115.13 million. The enterprise value is 131.80 million.
| Market Cap | 115.13M |
| Enterprise Value | 131.80M |
Important Dates
The next estimated earnings date is Friday, May 8, 2026.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 66.18M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +9.43% |
| Shares Change (QoQ) | +6.32% |
| Owned by Insiders (%) | 31.11% |
| Owned by Institutions (%) | 0.00% |
| Float | 27.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 95.46 |
| PB Ratio | -3.59 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -13.14 |
| EV / Sales | 108.15 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -15.85 |
Financial Position
The company has a current ratio of 0.67
| Current Ratio | 0.67 |
| Quick Ratio | 0.64 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.69 |
| Interest Coverage | -4.57 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -14.79% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -184.71% |
| Weighted Average Cost of Capital (WACC) | 10.68% |
| Revenue Per Employee | 33,503 |
| Profits Per Employee | -278,561 |
| Employee Count | 36 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 0.44 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +62.92% in the last 52 weeks. The beta is 1.38, so AB Science's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | +62.92% |
| 50-Day Moving Average | 8.49 |
| 200-Day Moving Average | 13.18 |
| Relative Strength Index (RSI) | 32.22 |
| Average Volume (20 Days) | 8,490 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AB Science had revenue of 1.21 million and -10.03 million in losses. Loss per share was -0.18.
| Revenue | 1.21M |
| Gross Profit | 1.09M |
| Operating Income | -6.14M |
| Pretax Income | -10.03M |
| Net Income | -10.03M |
| EBITDA | -5.53M |
| EBIT | -6.14M |
| Loss Per Share | -0.18 |
Balance Sheet
The company has 5.91 million in cash and 22.41 million in debt, with a net cash position of -16.50 million.
| Cash & Cash Equivalents | 5.91M |
| Total Debt | 22.41M |
| Net Cash | -16.50M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -32.09M |
| Book Value Per Share | -0.48 |
| Working Capital | -7.13M |
Cash Flow
In the last 12 months, operating cash flow was -8.08 million and capital expenditures -238,403, giving a free cash flow of -8.32 million.
| Operating Cash Flow | -8.08M |
| Capital Expenditures | -238,403 |
| Free Cash Flow | -8.32M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 90.75% |
| Operating Margin | -509.15% |
| Pretax Margin | -831.45% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AB Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.43% |
| Shareholder Yield | -9.43% |
| Earnings Yield | -8.71% |
| FCF Yield | -7.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |